Ventyx Equities

Ventyx Biosciences Begins Phase 2a Trial for Parkinson's Treatment VTX3232 Sep 7, 2024

Investigation Launches into Ventyx Biosciences for Alleged Insider Trading Jun 23, 2024

Investigation on Insider Trading Targets Ventyx Biosciences' Board; Shareholders Advised to Seek Information Jun 23, 2024

Ventyx Biosciences Shareholders May Have a Claim in Class Action Lawsuit Mar 24, 2024